Aygen, B., Demirtürk, N., Yıldız, O., Çelen, M. K., Çelik, İlhami, Barut, Şener, … Turkish Society of Clinical Microbiology and Infectious Diseases*, T. S. G. for V. H. of the. (2020). Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience. Turkish Journal of Gastroenterology, 31(4), 305–317. https://doi.org/10.5152/tjg.2020.19197